Request / Apply Now

To receive more information about Nova Southeastern University or to apply now, use one of the options below.

Request Information


Application Process

Degrees Offered:

Doctor of Pharmacy, Pharm.D.

  • Doctor of Pharmacy/Master of Business Administration dual degree

Doctor of Philosophy, Ph.D.

  • Molecular Medicine & Pharmacogenomics
  • Drug Development (Pharmaceutics)
  • Social & Administrative Pharmacy

          Stay Connected

 

Research Groups

Dr. Mutasem Qalaji's Research Team: Nanotechnology, Formulation and Drug Delivery

Research Interests: Nanoparticles, Nanocrystals, Orally Disintegrating Tablets (ODT), Drug Release, Dissolution, Absorption, Bioavailability, Non-invasive and patient-friendly drug delivery approach.

Dr. Mutasem Qalaji's Research Team


From left: Annette Losada, B.Sc. (Pharm. D. Student, Class 2015), Mutasem Rawas-Qalaji, B. Pharm., Ph.D (Assistant professor, College of Pharmacy, Nova Southeastern University), Alhusain Odah, B. Pharm. (Ph. D Student), Belacryst Mandez (Pharm. D. Student, Class 2015)

  • Reversed Micelles Platforms
    1. Fabrication, characterization, and evaluation of reversed micelles as a novel delivery platform for antitumor metalodrugs for potential treatment of cancer.
      • In collaboration with Professor Michael Johnson and Dr. David Richens and their teams an R15 NIH proposal has been submitted June 25, 2012.
  • Nanoparticles Platforms
    1. Nanocrystals fabrication and characterization of epinephrine using high shear fluid processor
      • Project is under progress. Current results are very promising. Epinephrine nanocrystals fabrication was successful using this novel technique and resulted in stable, uniform, and reproducible epinephrine nanocrystals at the nano size-range after a single pass.
      • Detailed technique and results were successfully filed by Technology Transfer Office at Nova Southeastern University for Provisional US Patent Application on June 15, 2012.
      • A manuscript is under preparation to be submitted for publication in a peer-reviewed journal.
  • Drug Release Studies
    1. Quantification and evaluation of xylitol release from baby tooth wipes for the potential prevention of dental carries in infants.
      • Project was in collaboration with the College of Dental Medicine. The amount of xylitol contained in Baby Tooth wipes, the maximum amount released, and the time required to be released were determined. Recommendations to dentist about the usefulness and the frequency of application of these wipes were achieved.
      • Abstract was accepted and poster was presented during the American Academy of Pediatric Dentistry (AAPD) Annual Session, San Diego, CA (May 24-27, 2012).
      • The results were presented through a podium presentation during the Research Day, College of Dental Medicine - Nova Southeastern University, May 14, 2012.
      • A manuscript is under preparation to be submitted for publication in a peer-reviewed dental journal.
  • Diffusion Studies
    1. In-vitro and Ex-vivo diffusion of epinephrine nanoparticles from a novel orally disintegrating tablet dosage form for the first-aid treatment of anaphylaxis
      • Project is under progress. Results obtained will be used to establish ex vivo/in vivo correlation.
    2. In-vitro diffusion of amlodipine nanoparticles from a novel orally disintegrating tablet dosage form for the treatment of hypertension
      • Project is under progress in collaboration with Dr. Enrique Nieves.
  • Formulation Studies
    1. Formulation and evaluation of a novel orally disintegrating epinephrine tablets using various superdisintegrats for the first-aid treatment of anaphylaxis
      • Project is partially completed and still under progress.
  • Bioavailability Studies
    1. Bioavailability of sublingually administered epinephrine nanocrystals formlated as orally disintegrating tablets for the first-aid treatment of anaphylaxis
      • Project is under progress.
    2. Bioavailability of sublingually administered taste-masked, orally disintegrating epinephrine tablets for the first-aid treatment of anaphylaxis
  • Stability Studies
    1. Evaluation of long-term stability of novel orally disintegrating epinephrine tablets at various storage conditions for the first-aid treatment of anaphylaxis
Mutasem Rawas-Qalaji, B. Pharm., Ph.D, Ousama Rachid, M.Sc., B. Pharm., Keith Simons, Ph.D.

Canadian Team - University of Manitoba:
Dr. Qalaji's Lab collaborates with Professor Keith Simons and his team at the Faculty of Pharmacy, University of Manitoba, Winnipeg, Canada.
Dr. Simons is a well-known scientist in the field of pharmacokinetics.
In the picture from left: Mutasem Rawas-Qalaji, B. Pharm., Ph.D (Assistant professor, College of Pharmacy, Nova Southeastern University), Ousama Rachid, M.Sc., B.Pharm. (Ph.D. Candidate, University of Manitoba), Keith Simons, Ph.D. (Professor, Faculty of Pharmacy, University of Manitoba)


Michael Johnson

Chemistry Team - New Mexico State University:
Recently, Dr. Qalaji's Lab started collaborating with Professor Michael Johnson and his team at Department of Chemistry & Biochemistry, New Mexico State University, Las Cruces, NM.
Dr. Johnson is an expert in the area of encapsulating metal complexes.


Dr. Enrique Nieves

Puerto Rico Team - Nova Southeastern University:
Dr. Qalaji's Lab collaborates with Dr. Enrique Nieves and his team at the College of Pharmacy, Nova Southeastern University in Ponce site, Puerto Rico.
Dr. Nieves has significant industrial experience.


Mutasem Rawas-Qalaji, B. Pharm., Ph.D and Daniel Yoo, DMD Pharm., Ph.D

Dentistry Team - Nova Southeastern University:
Dr. Qalaji's Lab collaborates with the College of Dental Medicine's faculty advisors at Nova Southeastern University, FL.
Dr. Daniel Yoo, Pediatric Dental Resident, conducted his residency research project and got trained in Dr. Qalaji's Lab.
In the picture from left: Mutasem Rawas-Qalaji, B. Pharm., Ph.D (Assistant professor, College of Pharmacy, Nova Southeastern University), Daniel Yoo, DDS (Pediatric Dental Resident, College of Dental Medicine, Nova Southeastern University)

Alhussain Aodah, B. Pharm.

Alhussain Aodah, B.Pharm.

  • Alhussain joined College of Pharmacy at Nova Southeastern University as a Ph.D. student in the Drug Development (Pharmaceutics) track in 2011.
  • Alhussain earned his B. Pharm. from King Saud University (KSA, 2008), and worked as a pharmacist in Security Force Hospital for one year, then joined Salman bin Abdulaziz University as Teaching Assistant.

Belacryst Mendez

Belacryst Mendez (Pharm.D. Student, Class 2015)

  • Belacryst joined College of Pharmacy at Nova Southeastern University as a Pharm.D. student in 2011.
  • Belacryst has been trained in Dr. Qalaji's Lab to perform diffusion studies, dissect mucosal membranes from pigs, fabricate drug-loaded nanoparticles using ionic gelation method and high sheer fluid process, measure nanoparticles/nanocrystals size and potential, perform FTIR scanning, use HPLC, manufacture tablets, and use lab notebook.
  • Belacryst is a coauthor of one peer-reviewed abstract that has been presented as a poster presentation during AAPS Annual Conference in Chicago, IL (Oct 14-18, 2012) and will be published in peer-reviewed AAPS journal.

Annette Losada and Belacryst Mendez

Annette Losada and Belacryst Mendez (Pharm.D. students, Class 2015) dissecting and excising sublingual mucosal membrane from pigs.


Annette Losada, B. Sc.

Annette Losada, B. Sc. (Pharm.D. Student, Class 2015)

  • Annette joined College of Pharmacy at Nova Southeastern University as a Pharm.D. student in 2011.
  • Annette has been trained in Dr. Qalaji's Lab to perform diffusion studies, dissect mucosal membranes from pigs, fabricate nanoparticles using ionic high sheer fluid process, measure nanocrystals size and potential, use HPLC, manufacture tablets, and use lab notebook.

Noor Daghistani, B. Sc.

Noor Daghistani, B. Sc. (Pharm.D. Student, Class 2014)

  • Noor joined College of Pharmacy at Nova Southeastern University as a Pharm.D. student in 2010.
  • Noor has been trained in Dr. Qalaji's Lab to perform diffusion studies, fabricate drug-loaded nanoparticles using ionic gelation method, measure nanoparticles size and potential, perform HPLC analysis, and use lab notebook.
  • Noor is a coauthor of one peer-reviewed abstract that has been presented as a poster presentation during AAPS Annual Conference in Chicago, IL (Oct 14-18, 2012) and will be published in peer-reviewed AAPS journal.

Mutasem Rawas-Qalaji, B. Pharm., Ph.D, Noor Daghistani, Pharm.D., and Keith Simons, Professor, Faculty of Pharmacy, University of Manitoba

Noor Daghistani, B. Sc. (Pharm.D. Student, Class 2014) presenting during AAPS Annual Conference in Chicago, IL (Oct 14-18, 2012).
In the picture from left: Mutasem Rawas-Qalaji, B. Pharm., Ph.D (Assistant professor, College of Pharmacy, Nova Southeastern University), Noor Daghistani, B. Sc. (Pharm.D. Student) and Keith Simons (Professor, Faculty of Pharmacy, University of Manitoba).


Bibi Khan, B. Sc.

Bibi Khan, B. Sc. (Pharm.D. Student, Class 2013)

  • Bibi joined College of Pharmacy at Nova Southeastern University as a Pharm.D. student in 2009.
  • Bibi has been trained in Dr. Qalaji's Lab to manufacture and evaluate ODT tablets, perform HPLC analysis, and use lab notebook.

Khyati Desai, Pharm. D.

Khyati Desai, Pharm.D. (International Class 2011)

  • Khyati joined College of Pharmacy at Nova Southeastern University as a Pharm.D. student in 2008.
  • Khyati has been trained in Dr. Qalaji's Lab to fabricate drug-loaded nanoparticles using ionic gelation, and emulsion-solvent evaporation methods, measure nanoparticles size and potential, perform FTIR scanning, perform HPLC analysis, and use lab notebook.
  • Khyati is a coauthor of two peer-reviewed abstracts that have been published in peer-reviewed journals (JPPS and AAPSJ) and were presented as poster presentations in:
  • Khyati presented during AAPS Annual Conference in Washington, DC (Oct 23-27, 2011) and was recognized for her presentation in SharkBytes News Letter of NSU in Nov 14, 2011.

Khyati Desai, Pharm.D. and Mutasem Rawas-Qalaji, B. Pharm., Ph.D

Khyati Desai, Pharm.D. (International Class 2011) and Mutasem Rawas-Qalaji, B. Pharm., Ph.D ( Assistant professor, College of Pharmacy, Nova Southeastern University) presenting during AAPS Annual Conference in Washington DC (Oct 23-27, 2011).


Jason Stubblefield (Pharm.D. Student, Class 2012)

  • Jason joined College of Pharmacy at Nova Southeastern University as a Pharm.D. student in 2008.
  • Jason has been trained in Dr. Qalaji's Lab to fabricate drug-loaded nanoparticles using double emulsion-solvent evaporation methods, measure nanoparticles size and potential, perform HPLC analysis, and use lab notebook.
  • Jason is a coauthor of one peer-reviewed abstract that has been published in peer-reviewed JPPS journal and was presented as poster presentation during CSPS Annual Symposium in Vancouver, Canada (Jun 2-5, 2010)

Nandita Koodie

Nandita Koodie (Pharm.D. Student, Class 2012)

  • Nandita joined College of Pharmacy at Nova Southeastern University as a Pharm.D. student in 2008.
  • Nandita has been trained in Dr. Qalaji's Lab to fabricate drug-loaded nanoparticles using emulsion-solvent evaporation methods, measure nanoparticles size, perform HPLC analysis, and use lab notebook.
Lab 1

From Top-Left: High Performance Liquid Chromatography (HPLC) with PDA and Electrochemical Detector (Waters), HPLC with ultraviolet detector (UV) (PerkinElmer), Fourier Transform Infrared Spectroscopy (FTIR, PerkinElmer), Differential Scanning Calorimetry (DSC 4000) with Thermogravimetric Analyzers (TGA 4000) (PerkinElmer), Sonifier 450 Analog (Branson), L4R Laboratory High Shear Mixer (Silverson), MicroFluidizer LV1 (Microfluidics), Nanosizer (Malvern), Mastersizer (Malvern), UV-1700 Spectrophotometer (Shimadzu), Avanti-J25 and L7 Ultrcentrifuge (Beckman), Fume Hood, NanoPur System (Barnstead), Allegra 21R Centrifuge (Beckman Coulter), Bench Top Freeze Dryer (ART), Flow-Through Vertical Franz Cell Diffusion Automated System and Static Vertical Franz Cell Diffusion System (PermeGear), Rotary Tablet Press (Colton), Hardness tester LIH-3 (Vanguard), USP Friability Tester LIC-1 (Vanguard), V-Shape Powder Mixer, USP Dissolution Apparatus (Type I and II) (Varian), Bath Sonicator/Degasser (Branson), Multivortexer (VWR) and Vortexer (Fisher), Temperature-Controlled shaker (Forma Scientific), Lab pictures.

Roebuck in Hollywood Gazette

President's Faculty Research Award was presented by Ray Ferrero, Ph.D. (President of Nova Southeastern University), in the center, and Andres Malave, Ph.D. (Dean of College of Pharmacy at Nova Southeastern University), on the left, in 2010 to Mutasem Rawas-Qalaji, B.Pharm., Ph.D (Assistant professor, College of Pharmacy, Nova Southeastern University), on the right.


Roebuck in Hollywood Gazette

Recognition Award was presented by Khaled Al-Hamoud, Ph.D. (President of Ebla University), on the left, in 2010 to Mutasem Rawas-Qalaji, B.Pharm., Ph.D (Assistant professor, College of Pharmacy, Nova Southeastern University), on the right.

Patents, Publications and Presentations

Intellectual Properties

  1. Rawas-Qalaji MM, Simons KJ, Gu X, Simons ER. Fast-Disintegrating Epinephrine Tablets for Buccal or Sublingual Administration. US Provisional Patent Application # 60/715,180. Filed Sep. 9, 2005. Assignee: University of Manitoba.
  2. Rawas-Qalaji MM, Simons KJ, Gu X, Simons ER. Fast-Disintegrating Epinephrine Tablets for Buccal or Sublingual Administration. US Provisional Patent Application # 60/759,039. Filed Jan. 17, 2006. Assignee: University of Manitoba.
  3. Rawas-Qalaji MM, Simons KJ, Gu X, Simons ER. Fast-Disintegrating Epinephrine Tablets for Buccal or Sublingual Administration. US Patent Application # 20070059361. Filed Sep. 8, 2006 and published March 15, 2007. Assignee: University of Manitoba (licensed April, 2006).
  4. Rawas-Qalaji MM, Simons KJ, Gu X, Simons ER. Fast-Disintegrating Epinephrine Tablets for Buccal or Sublingual Administration. International Patent Application (WIPO) # PCT/CA2006/001472, Filed Sep. 8, 2006 and published March 03, 2007. Assignee: University of Manitoba (licensed April, 2006).
  5. Rawas-Qalaji MM, Simons KJ, Gu X, Simons ER. Fast-Disintegrating Epinephrine Tablets for Buccal or Sublingual Administration. US Patent Application #20070202163. Filed Feb. 7, 2007 and published August 30, 2007. Assignee: University of Manitoba (licensed April, 2006).
  6. Rawas-Qalaji MM, Simons KJ, Gu X, Simons ER. Fast-Disintegrating Epinephrine Tablets for Buccal or Sublingual Administration.  International Patent Application (WIPO)  # PCT/CA2008/000197, Filed Jan. 31, 2008 and published August 14, 2008. Assignee: University of Manitoba (licensed April, 2006).
  7. Rachid OM, Rawas-Qalaji MM, Simons ER, Simons KJ. Novel Dissolution Apparatus Designed to Evaluate Sublingual Tablets. Provisional US Patent Application. Filed Nov 1, 2008.  Assignee: University of Manitoba
  8. Rawas-Qalaji MM, Nieves E., Simons KJ, Simons ER, Rachid OM. Composition and Method for Emergency Treatment of Anaphylaxis. Provisional US Patent Application # 61/309,136. Filed March 1, 2010.  Assignee: Nova Southeastern University
  9. Rawas-Qalaji MM, Nieves E., Simons KJ, Simons ER, Rachid OM. Epinephrine Nanoparticles, Methods of Fabrication Thereof, and Methods for Use Thereof for Treatment of Conditions Responsive to Epinephrine.  International Patent Application (WIPO) # PCT/US2011/026604. Filed March 1, 2011 and published September 9, 2011. Assignee: Nova Southeastern University
  10. Rawas-Qalaji MM, Rachid OM, Simons KJ, Simons ER. Epinephrine Nanoparticles Methods of Fabrication Thereof, and Methods for use Thereof for Treatment of Conditions Responsive to Epinephrine. US Provisional Patent Application, Filed October 21, 2011.  Assignee: Nova Southeastern University
  11. Rawas-Qalaji MM, Rachid OM, Simons KJ, Simons ER. Epinephrine Nanoparticles Methods of Fabrication Thereof, and Methods for use Thereof for Treatment of Conditions Responsive to Epinephrine. US Provisional Patent Application # 61/660,273, Filed June 15, 2012.  Assignee: Nova Southeastern University
  12. Rawas-Qalaji MM, Nieves E., Simons KJ, Simons ER, Rachid OM. Epinephrine Nanoparticles, Methods of Fabrication Thereof, and Methods for Use Thereof for Treatment of Conditions Responsive to Epinephrine. US Patent Application # 13/582,346. Filed August 31, 2012. Assignee: Nova Southeastern University
  13. Rawas-Qalaji MM, Rachid OM, Simons KJ, Simons ER. Epinephrine Nanoparticles Methods of Fabrication Thereof, and Methods for use Thereof for Treatment of Conditions Responsive to Epinephrine. International Application (WIPO) # PCT/US2012/xxxxxx. Filled October 19, 2012. Assignee: Nova Southeastern University

Peer-Reviewed Journal Publications (PubMed):

  1. Rawas-Qalaji MM, Simons ER, Simons KJ. Sublingual Epinephrine Tablets Versus Intramuscular Injection of Epinephrine: Dose Equivalence for Potential Treatment of Anaphylaxis. J Allergy Clin Immunol. 2006; 117(2):398-403. (Times Cited: 33, Impact factor: 11) DOI: 10.1016/j.jaci.2005.12.1310. PMID: 16461140. PMID: 16461140
  2. Rawas-Qalaji MM, Simons ER, Simons KJ. Fast-Disintegrating Sublingual Tablets: Effect of Epinephrine Load on Tablet characteristics. AAPS PharmSciTech. 2006;7(2): E41. (Times Cited: 21, Impact factor: 1.4) DOI: 10.1208/pt070241. PMCID: PMC2750292.
  3. Rawas-Qalaji MM, Simons ER, Simons KJ. Epinephrine for the Treatment of Anaphylaxis: Do all 40 mg Sublingual Epinephrine Tablet Formulations with Similar In Vitro Characteristics have the Same Bioavailability?. Biopharm Drug Dispos. 2006;27(9):427-435. (Times Cited: 5, Impact factor: 2.1) DOI: 10.1002/bdd.519. PMID: 17009337.
  4. Rawas-Qalaji MM, Simons ER, Simons KJ. Fast-Disintegrating Sublingual Tablets: Effect of Tablet Dimensions on Tablet Characteristics. Drug Dev Ind Pharm. 2007;33(5):523-530. (Times Cited: 5, Impact factor: 1.5) DOI: 10.1080/03639040600897150. PMID: 17520443.
  5. Rawas-Qalaji MM, Simons ER, Simons KJ. Long-Term Stability of Epinephrine Dispensed in Unsealed Syringes for the First-Aid Treatment of Anaphylaxis. Ann Allergy Asthma Immunol . 2009;102(6):500-503. (Times Cited: 10, Impact factor: 2.8) PMID: 19558009.
  6. Rachid OM, Simons FER, Rawas-Qalaji MM, Simons KJ. An Electronic Tongue: Evaluation of the Masking Efficacy of Sweetening and/or Flavoring Agents on the Bitter Taste of Epinephrine. AAPS PhamSciTech. 2010 Jun;11(2):550-7. (Times Cited: 9, Impact factor: 1.4) DOI: 10.1208/s12249-010-9402-3. PMCID: PMC2902344.
  7. Rachid OM, Rawas-Qalaji MM, Simons FER, Simons KJ. Dissolution Testing of Sublingual Tablets: A Novel In Vitro Method. AAPS PhamSciTech. 2011 Jun;12(2):544-52 . (Times Cited: 2, Impact factor: 1.4) DOI: 10.1208/s12249-011-9615-0. PMCID: PMC3134647.
  8. Rawas-Qalaji MM, Williams C. Advances in Ocular Drug Delivery. Curr Eye Res. 2012: 37(5), 345–356. (Times Cited: 0, Impact factor:1.5)  DOI: 10.3109/02713683.2011.652286. PMID: 22510004.
  9. Rachid OM, Rawas-Qalaji MM, Simons FER, Simons KJ. Rapidly-disintegrating sublingual tablets of epinephrine: role of non-medicinal ingredients in formulation development. Eur J Pharm Biopharm. 2012 Jun 7 (Epub ahead of print). (Times Cited: 0, Impact factor:4.3)  DOI: 10.1016/j.ejpb.2012.05.020. PMID: 22683694.
  10. Rachid OM, Rawas-Qalaji MM, Simons FER, Simons KJ. Epinephrine (Adrenaline) Absorption from New-Generation, Taste-Masked Sublingual Tablets: A Preclinical Study. Accepted for publication in J Allergy Clin Immunol. 2012 (Impact factor: 11)

Presentations and Peer-Reviewed Abstracts

  1. Rawas-Qalaji MM. The Role of b-Blockers in Heart Failure. Roche Symposium on Advances in the Management of Cardiovascular Diseases, Singapore, 1999
  2. Simons KJ, Rawas-Qalaji MM, Chan ES, Simons ER. Stability of Epinephrine in Pre-Loaded Syringes Located in Pediatric Allergy Clinics for the Prompt Emergency Treatment of Anaphylaxis. AAPSJ 2003; 5(S1): 002784 – Salt Lake City, UT (Oct 26-30, 2003)
  3. Rawas-Qalaji MM, Gu X, Simons ER, Simons KJ. Formulation of Fast-Disintegrating Sublingual Epinephrine Tablets for the Fist-Aid Treatment of Anaphylaxis Away from Health Care Facilities.AAPSJ 2004; 6(S1): 001340 - Baltimore, MD (Nov 7-10, 2004)
  4. Rawas-Qalaji MM, Simons ER, Simons KJ. Evaluation of the Effect of Changing Tablet Dimensions on the Characteristics of Fast-Disintegrating Sublingual Epinephrine Tablets for the Fist-Aid Treatment of Anaphylaxis Away from Health Care Facilities.AAPSJ 2004; 6(S1): 001328 - Baltimore, MD (Nov 7-10, 2004)
  5. Rawas-Qalaji MM, Simons ER, Simons KJ. Stability of Epinephrine in Buffers and Human Saliva at 37 °C.AAPSJ 2004; 6(S1): 001313 - Baltimore, MD (Nov 7-10, 2004)
  6. Rawas-Qalaji MM, Simons ER, Simons KJ. Pre-Loaded Epinephrine Syringes Stored Under Light in Dry or Humid Conditions at 38 °C for 5 Days are Stable for Emergency Treatment of Anaphylaxis.AAPSJ 2004; 6(S1): 001287 - Baltimore, MD (Nov 7-10, 2004)
  7. Alessi-Severini S, Rawas-Qalaji MM, Racher A, Collins D, Kozyrskyj A. Prescribing Trends for Celecoxib (Celebrex®) in the Province of Manitoba: Influence of Published Clinical Evidence and Provincial Reimbursement Status.AAPSJ 2004; 6(S1): 002927 - Baltimore, MD (Nov 7-10, 2004)
  8. Rawas-Qalaji MM, Simons ER, Simons KJ. Fast-Disintegrating Sublingual Epinephrine Tablets: Effect of Drug and Tablet Dimensions on Tablet Characteristics. AAPSJ 2005; 7(S2): 001041 - Nashville, TN (Nov 6-10, 2005)
  9. Rawas-Qalaji MM, Simons ER, Simons KJ. Fast-Disintegrating Sublingual Epinephrine Tablets: Long Term Stability Study. AAPSJ 2005; 7(S2): 001051 - Nashville, TN (Nov 6-10, 2005)
  10. Rawas-Qalaji MM, Simons ER, Simons KJ. Stability of Epinephrine Over Five Months at Four Different Non-Optimal Storage Conditions. J Allergy Clin Immunol 2005; 115(2): S136-137 - San Antonio, TX  (Mar 18-22, 2005)
  11. Rawas-Qalaji MM, Simons ER, Simons KJ. Epinephrine for the Treatment of Anaphylaxis: Sublingual Epinephrine Tablet Versus EpiPen®. J Allergy Clin Immunol 2006; 117(2): S85 - Miami Beach, FL (Mar 3-7, 2006)
  12. Rawas-Qalaji MM. Epinephrine for the Treatment of Anaphylaxis: Sublingual Epinephrine Tablet Versus EpiPen®. Podium presentation during Allergy session in the American Academy of Allergy Asthma and Immunology Annual Meeting in Miami Beach, Florida (Mar 3-7, 2006)
  13. Rawas-Qalaji MM, Simons ER, Simons KJ. Epinephrine for the Treatment of Anaphylaxis: Do all Sublingual Epinephrine Tablet Formulations with Similar In Vitro Characteristics have the Same Bioavailability? AAPSJ 2006; 8(S2): 001280  - San Antonio, TX (Oct 29-Nov 2, 2006)
  14. Rawas-Qalaji MM, Simons ER, Simons KJ. Fast-Disintegrating Sublingual Epinephrine Tablets: High Temperature Stability Study. J Allergy Clin Immunol 2007; 119(1);S32-33 - San Diego, CA (Feb 23-27, 2007)
  15. Rachid OM, Rawas-Qalaji MM, Simons FER, Simons KJ. Novel Epinephrine Sublingual Tablets:  Does the Grade of the Microcrystalline Cellulose Diluent Affect the Dissolution Rate? AAPSJ 2007; 9(S2): 002341 - San Diego, CA (Nov 10-15, 2007)
  16. Rachid OM, Rawas-Qalaji MM, Simons FER, Simons KJ. The Effect of Non-Medicinal Ingredients on the Dissolution of Epinephrine from Novel Sublingual Tablets. AAPSJ 2007; 9(S2): 002285 - San Diego, CA (Nov 10-15, 2007)
  17. Rawas-Qalaji MM. A Novel Approach for the Emergency Treatment of Anaphylaxis. School of Pharmacy-University of Waterloo, Ontario, Canada, June 2008
  18. Rachid OM, Rawas-Qalaji MM, Simons FER, Simons KJ. Novel Dissolution Apparatus Designed to Evaluate Sublingual Tablets. AAPSJ 2008; 10(S2): 000737 - Atlanta, GA (Nov 16-20, 2008)
  19. Rawas-Qalaji MM, Nieves E, Desai K, Stubblefield J, Rachid O, Simons KJ. In vitro Diffusion of Epinephrine Nanoparticles Using a Flow-Through Diffusion System. JPPS 2010; 13(3): 81-82s - Vancouver, Ca (Jun 2-5, 2010)
  20. Rawas-Qalaji MM. A Novel Approach for the treatment of Anaphylaxis. Ebla Private University, Aleppo, Syria, June 2010
  21. Rawas-Qalaji MM. A Novel Approach for the treatment of Anaphylaxis. Asia Pharmaceutical Industries, Aleppo, Syria, July 2010       
  22. Rachid OM, Rawas-Qalaji MM, Simons FER, Simons KJ. Epinephrine Autoinjectors for the First-Aid Treatment of Anaphylaxis: Epinephrine Contents Post-Expiry Date. AAPSJ 2010; 12(S2): T3045 - New Orleans, LA (Nov 14-18, 2010)
  23. Simons KJ, Rachid OM, Rawas-Qalaji MM, Simons FER. Epinephrine autoinjectors for the first-aid treatment of anaphylaxis: Epinephrine dose ejected after 11-13 years in controlled storage conditions. J Allergy Clin Immunol 2011; 127(2) SUPPL. 1: AB244 - San Francisco, CA (Mar 18-22, 2011)
  24. Rawas-Qalaji MM, Desai K, Rachid O, Simons FER, Simons KJ. Development of Epinephrine Nanoparticles Using Chitosan for the Treatment of Anaphylaxis. AAPSJ 2011; 13(S2): W4174 - Washington, D.C. (Oct 23-27, 2011)
  25. Rachid O, Rawas-Qalaji MM, Simons FER, Simons KJ. Rapidly-Disintegrating Sublingual Tablets of Epinephrine: Effect of Various Excipients on Disintegration and Dissolution. AAPSJ 2011; 13(S2): T3074 - Washington, D.C. (Oct 23-27, 2011)
  26. Rachid O, Rawas-Qalaji MM, Simons FER, Simons KJ. Outdated Epinephrine Autoinjectors: Integrity of the Delivery Systems/ Stability of the Contents. AAPSJ 2011; 13(S2): M1026 - Washington, D.C. (Oct 23-27, 2011)
  27. Rawas-Qalaji MM. Fabrication of Epinephrine Nanoparticles: Success and Failures. Graduate Seminar, College of Pharmacy-Nova Southeastern University, November 2011
  28. Rawas-Qalaji MM, Nieves E. Fabrication of Epinephrine Nanoparticles Using Microfluidizer Processor for the Treatment of Anaphylaxis. Presented at NanoFlorida 2011, The 4th Annual NanoScience Technology Symposium in Miami, FL (September 30-October 1, 2011)
  29. Simons KJ, Rachid O, Rawas-Qalaji MM, Wein M, Simons FER, Outdated Epinephrine Autoinjectors: Ejection Volume Integrity and Epinephrine Content and Dose. J Allergy Clin Immunol 2012; 129(1) SUPPL. 1: AB180 - Orlando, FL (Mar 2-6, 2012)
  30. Yoo D., Rawas-Qalaji MM. In Vitro Evaluation of Xylitol Release from Baby Tooth Wipes. American Academy of Pediatric Dentistry (AAPD) Annual Session, San Diego, CA (May 24-27, 2012)
  31. Rawas-Qalaji MM. Development of Epinephrine Nanoparticles Using Chitosan for the Treatment of Anaphylaxis. Research Day, College of Pharmacy-Nova Southeastern University, February 10, 2012
  32. Yoo D., Rawas-Qalaji MM. In Vitro Evaluation of Xylitol Release from Baby Tooth Wipes. Research Day, College of Dentistry- Nova Southeastern University, May 14, 2012
  33. Rawas-Qalaji MM, Nieves E. Fabrication of Epinephrine Nanoparticles Using Microfluidizer Processor for the Treatment of Anaphylaxis. Presented at the Association of Pharmacists of PR Meeting, Fajardo, PR  (Aug 23 - 25, 2012)
  34. Rawas-Qalaji MM, Rachid OM, Simons ER, Simons KJ. Fast-disintegrating Sublingual Epinephrine Tablets: Long Term Stability Study. AAPSJ 2012;14(S2): M1381 - Chicago, IL (Oct 14-18)
  35. Rawas-Qalaji MM, Mendez B, Daghistani N, Rachid OM, Simons ER, Simons KJ. Evaluation of the Development of Epinephrine Nanoparticles using Ionic Gelation Technique. AAPSJ 2012;14(S2): T3243 - Chicago, IL (Oct 14-18)
  36. Rachid O, Rawas-Qalaji MM, Simons FER, Simons KJ. New-Generation, Fast-Disintegrating Taste-Masked Epinephrine Sublingual Tablets: Preclinical Study. AAPSJ 2012;14(S2): M1291 - Chicago, IL (Oct 14-18)
  37. Simons FER, Rachid O, Rawas-Qalaji MM, Simons KJ. New-Generation, Fast-Disintegrating Taste-Masked Epinephrine Sublingual Tablets: Preclinical Study. Collegium Internationale Allergologicum (CIA), Jeju Island, South Korea (Oct 16-19, 2012)

Back to Research Groups